Back to Search Start Over

Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: Results from a nationwide Spanish registry

Authors :
Javier Segovia-Cubero
Daniela Hervás-Sotomayor
Gonzalo Barge-Caballero
Eduardo Barge-Caballero
Javier Muñiz
Gregorio Rábago-Juan-Aracil
Sonia Mirabet-Pérez
Marta Farrero-Torres
Juan F. Delgado
Diego Rangel-Sousa
Luis Almenar-Bonet
Ana Portolés-Ocampo
José González-Costello
María G. Crespo-Leiro
Francisco González-Vílchez
Luis de la Fuente-Galán
José Luis Lambert-Rodríguez
María A. Castel-Lavilla
Manuel Martínez-Sellés
Iris P. Garrido-Bravo
Source :
ABACUS. Repositorio de Producción Científica, Universidad Europea (UEM), RUC. Repositorio da Universidade da Coruña, Universitat Oberta de Catalunya (UOC), Interactive Cardiovascular and Thoracic Surgery, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, RUC: Repositorio da Universidade da Coruña, Universidade da Coruña (UDC), r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Publication Year :
2019

Abstract

OBJECTIVES To investigate the potential clinical benefit of an intra-aortic balloon pump (IABP) in patients supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO) as a bridge to heart transplantation (HT). METHODS We studied 169 patients who were listed for urgent HT under VA-ECMO support at 16 Spanish institutions from 2010 to 2015. The clinical outcomes of patients under simultaneous IABP support (n = 73) were compared to a control group of patients without IABP support (n = 96). RESULTS There were no statistically significant differences between the IABP and control groups with regard to the cumulative rates of transplantation (71.2% vs 81.2%, P = 0.17), death during VA-ECMO support (20.6% vs 14.6%, P = 0.31), transition to a different mechanical circulatory support device (5.5% vs 5.2%, P = 0.94) or weaning from VA-ECMO support due to recovery (2.7% vs 0%, P = 0.10). There was a higher incidence of bleeding events in the IABP group (45.2% vs 25%, P = 0.006; adjusted odds ratio 2.18, 95% confidence interval 1.02–4.67). In-hospital postoperative mortality after HT was 34.6% in the IABP group and 32.5% in the control group (P = 0.80). One-year survival after listing for urgent HT was 53.3% in the IABP group and 52.2% in the control group (log rank P = 0.75). Multivariate adjustment for potential confounders did not change this result (adjusted hazard ratio 0.94, 95% confidence interval 0.56–1.58). CONCLUSIONS In our study, simultaneous IABP therapy in transplant candidates under VA-ECMO support did not significantly reduce morbidity or mortality. Sin financiación 1.675 JCR (2019) Q3, 98/138 Cardiac & Cardiovascular Systems, 123/210 Surgery; Q4, 53/64 Respiratory System 0.660 SJR (2019) Q2, 137/362 Cardiology and Cardiovascular Medicine, 63/147 Pulmonary and Respiratory Medicine, 138/451 Surgery No data IDR 2019 UEM

Details

ISSN :
15699293
Database :
OpenAIRE
Journal :
ABACUS. Repositorio de Producción Científica, Universidad Europea (UEM), RUC. Repositorio da Universidade da Coruña, Universitat Oberta de Catalunya (UOC), Interactive Cardiovascular and Thoracic Surgery, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, RUC: Repositorio da Universidade da Coruña, Universidade da Coruña (UDC), r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Accession number :
edsair.doi.dedup.....2546f75031be33f21c1d9af51463efe2